Discovery’s B4 Tour – Bridging Biomarker Breakthroughs to Bedsides
Join Discovery Life Sciences on the Bridging Biomarker Breakthroughs to Bedsides (B4) Tour, an in-person series spotlighting leading biomarker innovation in precision medicine. This exclusive program brings together leading experts to share practical insights and spark collaboration.
Attendees will discover advanced technologies in genomics, proteomics, molecular pathology, and cell biology, all underpinned by CLIA/CAP-accredited, GCLP-compliant labs, including our Health Institute facility in Kassel, Germany, enabling IVDR-compliant studies across Europe.
This tour offers focused sessions, real-world examples, and networking in key biohubs to accelerate precision medicine programs.